Opioid agonist treatment take-home doses (‘carries’): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA? | Zendy

AI Assistant Blog Pricing

Opioid agonist treatment take-home doses (‘carries’): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.